Dr. Marion has a professional interest in celiac disease, colon polypectomy, colon polyps, colonoscopy, Crohn’s Disease, inflammatory bowel disease and ulcerative colitis. He is currently the principal investigator of two clinical trials. One is a multicenter study of higher versus standard adalimumab dosing regimens for induction and maintenance therapy in ulcerative colitis patients. The other focuses on the efficacy and safety of two adalimumab induction regiments in Crohn’s Disease patients showing evidence of mucosal ulceration.
Dr. Marion earned his medical degree at Columbia University College of Physicians and Surgeons in New York and completed his internal medicine residency at NewYork-Presbyterian/Columbia University Medical Center, also in New York. He completed his GI fellowship at Mount Sinai Hospital.
More articles on GI/endoscopy:
Giving thanks in GI: 5 gastroenterologists on what they are most grateful for
New York’s CRC public health program drives screening rates up to 70%
Dr. Noel Fajardo to open LV Surgery Center in Nevada: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
